Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma. (Q42230815)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

adaptive radiation therapy

10 March 2020

main subject

Epstein–Barr virus

0 references

0 references

author

Brigette Ma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Benny Chung-Ying Zee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

S F Leung

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

K C A Chan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

E P Hui

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

F Mo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

K C K Chow

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

L Leung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

K W Chu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Y M D Lo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

A T C Chan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

17 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

1204-1208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU117

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU117

A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU117

Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU117

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU117

Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU117

A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU117

Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU117

Natural history of progression after PSA elevation following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU117

Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU117

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDU117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638904%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference